期刊文献+

同步放化联合腹腔热疗治疗宫颈癌的疗效观察 被引量:2

下载PDF
导出
摘要 目的:探讨同步放化联合腹腔热疗治疗宫颈癌的方法及其疗效。方法:选择2005年-2008年入住我院经临床诊断为宫颈癌患者50例,将其随机地均分为对照组与治疗组。对照组:首先采用全盆外照DT:25.2GY/14F+全盆四野外照DT:21.6GY/12F+192Ir后装腔内放疗(A点量DT:35-40GY),同步给予顺铂40mg每周一次化疗,共6周;治疗组:在对照组的基础上外加腹腔热疗,每周2次,共4周。比较两组的近期疗效、5年生存率及毒副反应等情况。结果:(1)治疗后对照组与治疗组缓解率分别为92%、100%,5年生存率对照组与治疗组分别为40-50%、50-70%;(2)对照组与治疗组的主要毒副反应出现的比率存在统计学差异(P<0.05)结论:同步放化联合腹腔热疗治疗宫颈癌的疗效尤佳,可提高患者生存率,降低毒副反应,应在临床应用中加以推广。
出处 《中国高等医学教育》 2013年第2期134-135,共2页 China Higher Medical Education
  • 相关文献

参考文献6

二级参考文献29

  • 1黄曼妮,吴令英,高菊珍.宫颈癌的同步放化疗[J].癌症进展,2004,2(5):320-326. 被引量:60
  • 2张国楠,宋水勤.宫颈癌动脉化疗进展[J].实用妇产科杂志,2006,22(8):458-460. 被引量:23
  • 3Symonds P. Chemoradiafion: the new gold standard for non2surgicahreatment of cervical cancer[ J]. Clinical ontology, 2002, 14 (3) : 2012202.
  • 4Tsuda H, TanakaM, Manabe T, et al. Phase I study of combined radiation, hyperthermia and intra2arterial carbop latin for local recur2 rence of cervical cancerI J]. Ann Oncol, 2003, 14 (2) : 2982303.
  • 5Jones EL, Samulski TV, DewhirstMW, et al. A p riot Phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for lo2 cally advanced cervical carcinoma [ J ]. Cancer, 2003.98 (2) : 2772282.
  • 6Westermann AM, Jones EL, Schem BC, et al. First results of tri2. ple2modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma[ J ]. Cancer, 2005, 104 (4) : 7632770.
  • 7Harima Y, Nagata K, Harima K, et al. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma [ J]. Int J Hyperthermia, 2001, 17 (2) : 972105.
  • 8Koivusalo R,Krausz E,Helenius H,et al.Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA-mediated degradation of human papillomavirus 18 E6 mRNA,opposite effect of siRNA in combination with different drugs[ J ].Mol Pharmacol,2005,68(2):372-382.
  • 9Lee K H,Yim E K,Kim C J,et al.Proteomic analysis of anticancer effects by paclitaxel treatment in cervical cancer cells[ J ].Gynecol Oncol,2005,98(1):45-53.
  • 10Araki S,Miyagi Y,Kawanishi K,et al.Neoadjuvant treatment with doeetaxel and the effects of irradiation for human ovarian adenocarcinoma and cervical squamous cell carcinoma in vitro[ J].Acta Med Okayama,2002,56 (1):13-18.

共引文献97

同被引文献27

  • 1Jemal A,Bray F,Center MM,et al.Global cancer statistics [J].CA Cancer J Clin,2011,61(2):69-90.
  • 2Shi JF,Qiao YL,Smith JS,et al.Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia[J].Vaccine,2008,26(Suppl 12):M53-M59.
  • 3Franckena M.Hyperthermia for the treatment of locally advanced cervix cancer [M].Rotterdam:Erasmus University Rotterdam,2010:9-14.
  • 4Kuzuya K.Chemoradiotherapy for uterine cancer:current status and perspectives [J].Int J Clin Oncol,2004,9(6):458-470.
  • 5Chichel A,Skowronek J,Kubaszewska M,et al.Hyperthermiadescription of a method and a review of clinical applications [J].Rep Pract Oncol Radiother,2007,12(5):267-275.
  • 6Zolzer F,Streffer C.G2-phase delays after irradiation andlor heat treatment as assessed by two-parameter flow cytometry [J].Radiat Res,2001,155(1 pt 1):50-56.
  • 7Marchettini P,Sugarbaker PH.Thermal enhancement of new chemotherapeutic agents at moderate hyperthermia [J].Ann Surg Oncol,2003,10(4):463-468.
  • 8Takahashi I,Emi Y,Hasuda S,et al.Clinical application of hyperthermia combined with anticancer drugs for the treatment of solid tumors [J].Surgery,2002,131(1 Suppl):S78-S84.
  • 9Sawaji Y,Sato T,Takeuchi A,et al.Anti-angiogenic action of hyperthermia by suppressing gene expression and production of tumour-derived vascular endothelial growth factor in vivo and in vitro[J].Br J Cancer,2002,86(10):1597-1603.
  • 10Frey B,Weiss EM,Rubner Y,et al.Old and new facts about hyperthermia-induced modulations of the immune system [J].Int J Hyperthermia,2012,28(6):528-542.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部